• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: SIEMENS HEALTHCARE DIAGNOSTICS INC - GLASGOW STRATUS CS

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

SIEMENS HEALTHCARE DIAGNOSTICS INC - GLASGOW STRATUS CS Back to Search Results
Catalog Number 10453531
Device Problem High Test Results (2457)
Patient Problem No Known Impact Or Consequence To Patient (2692)
Event Date 05/15/2015
Event Type  malfunction  
Event Description
Customer reported falsely high troponin results on the instrument.
 
Manufacturer Narrative
There was no harm to the patient due to this event.Siemens team investigated customer return patient sample.Investigation: a plasma sample from the patient sample in question was returned to the (b)(6) site - this sample was not from the initial draw but from the second draw.One (1) replicate of the plasma sample was tested on one (1) stratus cs analyzer (b)(4) using testpak lot 235033002.The initial result obtained was 3.82 ng/ml.A 500 ul of the plasma was then treated with a blocking agent (hbt) from (b)(4) which is composed of specific binders which inactivate heterophilic antibodies.The plasma sample incubated at rt for 1 hour with the blocking reagent and was then tested on the same stratus cs analyzer.The result obtained was 2.46 ng/ml.This result demonstrated a decrease in ctni concentration.When this ctni decrease is considered with what is stated in the product material for the blocking agent, which states if a patient sample is one with an extremely strong heterophilic interference, the blocking agent is unable to block all of the assay interference.Based on these results along with the negative vista result, it appears that there was heterophile antibody interference.Conclusion: along with a negative troponin result on the alternate instrument (siemens vista) at the customer site, internal testing concluded that heterophilic antibody interference caused the false positive troponin result.Treatment with heterophilic antibody blocker reduced the clinical result from 3.82 ng/ml to 2.46 ng/ml.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
STRATUS CS
Type of Device
STRATUS CS
Manufacturer (Section D)
SIEMENS HEALTHCARE DIAGNOSTICS INC - GLASGOW
glasgow business community
newark DE 19702
Manufacturer (Section G)
SIEMENS HEALTHCARE DIAGNOSTICS INC - GLASGOW
glasgow business community
newark DE 19702
Manufacturer Contact
steven andberg
2 edgewater drive
norwood, MA 02062
7812693655
MDR Report Key4827556
MDR Text Key21555026
Report Number1217157-2015-00071
Device Sequence Number1
Product Code DAP
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
K051650
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type User Facility,Company Representative
Reporter Occupation Other Health Care Professional
Type of Report Initial
Report Date 05/17/2015
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Other Health Care Professional
Device Catalogue Number10453531
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 05/17/2015
Initial Date FDA Received06/09/2015
Was Device Evaluated by Manufacturer? Yes
Is the Device Single Use? No
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Age37 YR
-
-